Sangamo inventory crashes 50% after Pfizer terminates HemoA gene remedy deal

2 months ago

Investing.com -- Sangamo Therapeutics Inc (NASDAQ:SGMO) introduced on Monday that Pfizer (NYSE:PFE) has ended their partnership to co-develop a gene…

Sangamo inventory crashes 50% after Pfizer terminates HemoA gene remedy deal

2 months ago

Investing.com -- Sangamo Therapeutics Inc (NASDAQ:SGMO) introduced on Monday that Pfizer (NYSE:PFE) has ended their partnership to co-develop a gene…

Concentrix EVP Cormac Twomey sells $22,025 in inventory

2 months ago

Concentrix Corp's (NASDAQ:CNXC) Govt Vice President of International Operations & Supply, Cormac J. Twomey, not too long ago offered a…

Wolfe Analysis outlines 5 potential surprises for 2025

2 months ago

Investing.com -- Wolfe Analysis not too long ago outlined 5 potential surprises for 2025 together with a doable Fed pivot…

Subsequent nuclear talks between Iran and three European nations due on Jan 13

2 months ago

DUBAI (Reuters) - The subsequent spherical of nuclear talks between Iran and three European nations will happen on Jan. 13…

4 explanation why the post-election S&P 500 rally has been shedding steam: Yardeni

2 months ago

Investing.com -- The post-election rally within the S&P 500 has been faltering since early December, peaking at a document excessive…

Sprout social CEO Ryan Barretto sells shares price $520,615

2 months ago

Ryan Paul Barretto, CEO of Sprout Social, Inc. (NASDAQ:SPT), lately offered 16,800 shares of the corporate’s Class A Frequent Inventory.…

Sprout social CEO Ryan Barretto sells shares value $520,615

2 months ago

Ryan Paul Barretto, CEO of Sprout Social, Inc. (NASDAQ:SPT), lately offered 16,800 shares of the corporate’s Class A Widespread Inventory.…

China’s GDP development on monitor to satisfy 2024 official goal

2 months ago

Investing.com -- China's gross home product (GDP) is projected to develop round 5% for your entire yr of 2024, as…

Meeting Biosciences director Houghton buys $49,997 in inventory

2 months ago

Michael Houghton, a director at Meeting Biosciences, Inc. (NASDAQ:ASMB), not too long ago acquired 3,202 shares of the corporate’s widespread…